Calidi Biotherapeutics, Inc. (CLDI): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2025-08-08; 1-for-16, first reflected in a filing dated 2026-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Figures left out. The filed Weighted Average Diluted Shares for the year ended 2025-12-31 is not shown: share count out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.

8.01M
Year ended 2024-12-31
8.51M2022-12-31: 8.51M2023-12-31: 1.69M2024-12-31: 8.01M8.01M
2022-12-31 Weighted Average Diluted Shares (shares) 2024-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2024-12-318.01M+374.8%2025-03-31, From 2024-01-01
2023-12-311.69Mn/c2025-03-31, From 2023-01-01
2022-12-318.51Mn/a2024-03-15, From 2022-01-01